Home Tags CPhI

Tag: CPhI

Experts Forecasts CMOs to Benefit from Double Digit Approvals of ADCs

The global ADC therapeutics market is expected to grow to US $ 4bn by 2023, with double digit approvals within 3-years. Novel payloads that...

CPhI Worldwide Attracts a Record of 42,000 Attendees

CPhI Worldwide, organised by UBM EMEA, closed its 27th edition with pre-audit figures indicating a record-breaking attendance of over 42,000 visitors and 2,550+ exhibitors....
CPhl worldwide

CPhI Report Sees ADCs as a Key Driver of Tomorrow’s Healthcare

In the first section of the 2013 annual report and industry expert panel, analysts at CPhI Worldwide and CPhI Pharma Evolution describe how they expect that antibody-drug conjugates or ADCs will become a major product group within the oncology market.

DOWNLOAD